Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines, wishes to provide an update on its ...

Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that AstraZeneca has ...

CD Formulation, a leading contract research and development biotechnology firm, highlights the critical importance of compatibility studies between drug formulations and their respective packaging ...

Research Nester’s recent market research analysis on “Patient Engagement Solutions Market: Global Demand Analysis & Opportunity Outlook 2037” delivers a detailed competitor’s analysis and a detailed ...

BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence software, designed to ...

ABPI has today (Monday) welcomed a new report from The King’s Fund which explores the positive impacts of NHS and industry partnerships.

After successful sandpit events in Liverpool and London earlier this year, iiCON (Infection Innovation Consortium) is excited to announce 11 new projects during World AMR Awareness Week. These ...

ICR Healthcare, a leading global strategic communication, investor relations and capital markets advisory firm specializing in the healthcare sector, today hosts its 12th Annual Healthcare Conference: ...